ranimustine has been researched along with Acute Myelogenous Leukemia in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujimoto, Y; Ishihara, S; Izumi, H; Kaneko, K; Kato, M; Kuraishi, Y; Nagase, D; Natori, K; Umeda, M | 1 |
| Fujimoto, N; Fujita, S; Fujitake, H; Harashima, S; Hirata, M; Hirota, Y; Horiuchi, A; Hoshino, A; Kamiya, O; Kanamaru, R; Kanayama, Y; Katoh, Y; Kawagoe, H; Kimura, K; Kitani, T; Kojima, T; Konda, C; Masaoka, T; Matsubuchi, T; Miyazaki, T; Morioka, M; Musashi, M; Nagai, K; Nagata, K; Nakamura, T; Nakao, I; Oguro, M; Ohara, K; Ohhashi, Y; Ohkubo, A; Ohno, R; Okamoto, Y; Saitoh, H; Saitoh, T; Sakai, Y; Sakurada, K; Sasada, M; Sasaki, T; Shibata, H; Takada, T; Takagi, T; Takubo, T; Taniguchi, N; Tsubaki, K; Tsubakio, T; Wakui, A; Yamada, K; Yasunaga, K; Yokoyama, M; Yonezawa, T | 1 |
| Kikuchi, H; Nagano, T; Nasu, M; Ohtsuka, E; Saburi, Y; Satoh, J; Taniguchi, K; Tezono, K | 1 |
| Shimokawa, T; Takeyama, H; Watanabe, E; Yamada, H | 1 |
| Harashima, S; Okamura, T; Takaki, K; Umeno, M | 1 |
2 trial(s) available for ranimustine and Acute Myelogenous Leukemia
| Article | Year |
|---|---|
[Phase II study with methyl-6[[[2-chloroethyl) nitrosoamino] carbonyl] amino]-6-deoxy-alpha-D-glucopyranoside (MCNU) in hematological malignancies].
Topics: Adult; Aged; Clinical Trials as Topic; Female; Humans; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Lymphoma; Male; Middle Aged; Multiple Myeloma; Nitrosourea Compounds | 1983 |
[A clinical study of sixteen polycythemia vera cases--acute myeloblastic leukemia in patients with polycythemia vera].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Hypertension; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitobronitol; Nitrosourea Compounds; Polycythemia Vera; Prognosis | 1994 |
3 other study(ies) available for ranimustine and Acute Myelogenous Leukemia
| Article | Year |
|---|---|
[Four cases of therapy-related leukemia in multiple myeloma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Humans; Leukemia, Myeloid, Acute; Male; Melphalan; Middle Aged; Multiple Myeloma; Neoplasms, Second Primary; Nitrosourea Compounds; Prednisolone; Prednisone; Vincristine | 2007 |
[Essential thrombocythemia transformed to minimally differentiated acute myeloid leukemia].
Topics: Cell Transformation, Neoplastic; Female; Humans; Leukemia, Myeloid, Acute; Middle Aged; Nitrosourea Compounds; Thrombocytosis | 1995 |
[A case of myelofibrosis that developed polycythemia vera following treatment with ranimustine and then acute myelogenous leukemia (M0)].
Topics: Antineoplastic Agents; Chromosome Aberrations; Chromosome Disorders; Disease Progression; Fatal Outcome; Female; Humans; Leukemia, Myeloid, Acute; Lymphocyte Activation; Middle Aged; Nitrosourea Compounds; Polycythemia; Primary Myelofibrosis | 1996 |